Our findings provide evidence for the involvement of ZNF224 in the survival of CLL cells via NF-κB pathway modulation, and also suggest ZNF224 as a prognostic and predictive molecular marker of CLL disease. The gene discussed is ZNF224; the disease is B-cell chronic lymphocytic leukemia.